Several studies have suggested that WWOX polymorphic variants are consistently associated with more aggressive phenotypes and poor outcomes in numerous malignant diseases, including esophageal squamous cell carcinoma, thyroid carcinoma, pancreatic cancer, and lung cancer [36, 40–42]. The gene discussed is WWOX; the disease is lung carcinoma.